Cognition Therapeutics, Inc.

NASDAQ:CGTX

Biotechnology

Healthcare
$0.60 -0.70%

-$0.01 today

Market cap
$57.12M
Beta
1.75
P/E (TTM)
-6.4
EPS (TTM)
-$0.22
52W Low $0.25High $3.83

Volume 0.33M

Average 1.23M

Balance Sheet

Inspect the capital base behind the business.

Assets

$48.39M

FY 2025 · Annual

+60.1% YoY

Liabilities

$14.12M

FY 2025 · Annual

+22.9% YoY

Equity

$34.27M

FY 2025 · Annual

+82.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents54.72M41.56M29.92M25.01M36.81M
Short-term Investments00000
Net Receivables2.27M3.67M1.28M2.69M9.92M
Inventory00000
Other Current Assets11K03.02M01.26M
Total Current Assets58.99M47.65M34.22M29.56M47.99M
Property, Plant & Equipment (Net)145K1.05M941K679K399K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets01.73M000
Total Non-current Assets145K2.78M941K679K399K
Total Assets59.14M50.43M35.16M30.23M48.39M
Account Payables4.17M3.22M3.7M1.98M1.12M
Short-term Debt0634K544K279K307K
Tax Payables00000
Deferred Revenue753K1.7M1.7M1.07M367K
Other Current Liabilities2.48M870K1.17M1.53M1.57M
Total Current Liabilities7.86M7.8M10.17M11.14M13.92M
Long-term Debt00000
Deferred Tax Liabilities0(695K)000
Deferred Revenue (Non-current)01.69M000
Other Non-current Liabilities0695K000
Total Non-current Liabilities02.38M520K342K195K
Total Liabilities7.86M10.18M10.69M11.48M14.12M
Common Stock22K29K32K60K90K
Retained Earnings(94M)(115.4M)(141.19M)(175.16M)(198.65M)
Accumulated OCI(198K)(199K)(195K)00
Other Stockholders Equity00000
Minority Interest00000
Total Equity51.27M40.25M24.47M18.75M34.27M
Total Debt01.48M1.24M814K638K
Net Debt(54.72M)(40.08M)(28.68M)(24.2M)(36.17M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$31.1M
Receivables$3.7M
Other Current$1.0M
Total Current Assets$35.8M
PP&E (Net)$326.0K
Total Non-current Assets$326.0K
Total Assets$36.1M

Analysis

Selected assets total $36.1M for Latest. The largest visible component is Cash & Equivalents at $31.1M, about 86.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportOct 22, 2026
10-QQuarterly reportAug 7, 2026
8-KCurrent reportAug 6, 2026

How much cash does CGTX have?

Cognition Therapeutics, Inc. (CGTX) reported $36.81M in cash and equivalents in fiscal 2025.

How much debt does CGTX carry?

Cognition Therapeutics, Inc. (CGTX) reported $638,000.00 of total debt, with net debt of -$36.17M.